bluebird bio Inc (NASDAQ:BLUE)

180.35
Delayed Data
As of Jul 20
 +1.40 / +0.78%
Today’s Change
85.65
Today|||52-Week Range
236.17
+1.26%
Year-to-Date
Dopamine and the Weather, Part 2
Jul 13 / Zacks.com - Paid Partner Content
Celgene, Acceleron Report Positive Data on Thalassemia Drug
Jul 10 / Zacks.com - Paid Partner Content
Celgene Reports Positive Data on Tecentriq, Abraxane Study
Jul 11 / Zacks.com - Paid Partner Content
 

Today’s Trading

Previous close178.95
Today’s open179.00
Day’s range179.00 - 181.45
Volume463,673
Average volume (3 months)839,493
Market cap$9.0B
Data as of 4:00pm ET, 07/20/2018

Growth & Valuation

Earnings growth (last year)-9.05%
Earnings growth (this year)-22.10%
Earnings growth (next 5 years)-64.66%
Revenue growth (last year)+475.58%
P/E ratioNM
Price/Sales218.86
Price/Book5.49

Competitors

----
NBIXNeurocrine Bioscienc...-0.38-0.37%
TECHBio-Techne Corp+2.53+1.64%
EXASExact Sciences Corp+0.01+0.01%
Data as of 4:00pm ET, 07/20/2018

Financials

Next reporting dateAugust 15, 2018
EPS forecast (this quarter)-$2.37
Annual revenue (last year)$35.4M
Annual profit (last year)-$335.6M
Net profit margin-947.42%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Nick Leschly
Chief Operating Officer
Susanna G. High
Corporate headquarters
Cambridge, Massachusetts

Forecasts